Philips shareholders approve all proposals at the AGM 2025
Philips (NYSE: PHG) shareholders have approved all proposals at their Annual General Meeting (AGM) 2025. Key approvals include the re-appointment of Indra Nooyi and Chua Sock Koong as Supervisory Board members, the appointment of Bob White as a new Supervisory Board member, and the re-appointment of Marnix van Ginneken to the Board of Management. Shareholders also approved a dividend of EUR 0.85 per common share, payable in shares or cash, and adopted the financial statements for 2024.
The meeting also granted authorization for share issuance, share buybacks, and share cancellation. David Pyott concluded his tenure after a decade of service on the Supervisory Board.
Gli azionisti di Philips (NYSE: PHG) hanno approvato tutte le proposte durante l'Assemblea Annuale del 2025. Tra le approvazioni principali vi sono la riconferma di Indra Nooyi e Chua Sock Koong come membri del Consiglio di Sorveglianza, la nomina di Bob White come nuovo membro del Consiglio di Sorveglianza e la riconferma di Marnix van Ginneken nel Consiglio di Amministrazione. Gli azionisti hanno inoltre approvato un dividendo di 0,85 EUR per azione ordinaria, pagabile in azioni o in contanti, e hanno adottato il bilancio per il 2024.
Durante la riunione è stata anche concessa l'autorizzazione all'emissione di azioni, al riacquisto di azioni e alla loro cancellazione. David Pyott ha concluso il suo mandato dopo dieci anni di servizio nel Consiglio di Sorveglianza.
Los accionistas de Philips (NYSE: PHG) aprobaron todas las propuestas en la Junta General Anual (JGA) de 2025. Las principales aprobaciones incluyen la reelección de Indra Nooyi y Chua Sock Koong como miembros del Consejo de Supervisión, el nombramiento de Bob White como nuevo miembro del Consejo de Supervisión y la reelección de Marnix van Ginneken en el Consejo de Administración. Los accionistas también aprobaron un dividendo de 0,85 EUR por acción ordinaria, pagadero en acciones o efectivo, y adoptaron los estados financieros de 2024.
La reunión también autorizó la emisión de acciones, la recompra de acciones y la cancelación de las mismas. David Pyott concluyó su mandato tras una década de servicio en el Consejo de Supervisión.
필립스(NYSE: PHG) 주주들은 2025년 연례 총회에서 모든 안건을 승인했습니다. 주요 승인 사항으로는 인드라 누이와 추아 속 쿵의 감사위원회 재선임, 밥 화이트의 신규 감사위원회 위원 임명, 그리고 마르닉스 반 긴네켄의 경영진 재선임이 포함됩니다. 주주들은 또한 주당 0.85 유로의 배당금을 주식 또는 현금으로 지급하는 것을 승인하고, 2024년 재무제표를 채택했습니다.
총회에서는 주식 발행, 자사주 매입 및 소각에 대한 권한도 부여되었습니다. 데이비드 파이엇은 10년간의 감사위원회 임기를 마쳤습니다.
Les actionnaires de Philips (NYSE : PHG) ont approuvé toutes les propositions lors de l'Assemblée Générale Annuelle (AGA) 2025. Les principales approbations comprennent la réélection de Indra Nooyi et Chua Sock Koong en tant que membres du Conseil de Surveillance, la nomination de Bob White en tant que nouveau membre du Conseil de Surveillance, ainsi que la réélection de Marnix van Ginneken au Conseil d'Administration. Les actionnaires ont également approuvé un dividende de 0,85 EUR par action ordinaire, payable en actions ou en espèces, et adopté les états financiers pour 2024.
L'assemblée a également autorisé l'émission d'actions, le rachat d'actions et leur annulation. David Pyott a terminé son mandat après dix ans de service au Conseil de Surveillance.
Die Aktionäre von Philips (NYSE: PHG) haben auf ihrer Hauptversammlung 2025 alle Vorschläge genehmigt. Zu den wichtigsten Beschlüssen zählen die Wiederbestellung von Indra Nooyi und Chua Sock Koong als Mitglieder des Aufsichtsrats, die Ernennung von Bob White als neues Aufsichtsratsmitglied sowie die Wiederbestellung von Marnix van Ginneken in den Vorstand. Die Aktionäre stimmten außerdem einer Dividende von 0,85 EUR je Stammaktie zu, zahlbar in Aktien oder bar, und verabschiedeten den Jahresabschluss für 2024.
Die Versammlung erteilte zudem eine Ermächtigung zur Ausgabe von Aktien, zum Rückkauf und zur Vernichtung von Aktien. David Pyott beendete nach zehn Jahren seine Tätigkeit im Aufsichtsrat.
- None.
- None.
Insights
Philips shareholders approved a EUR 0.85 dividend and maintained board continuity with strategic addition of health technology expert Bob White.
The press release details the outcomes of Philips' Annual General Meeting 2025, centered on corporate governance matters and shareholder returns. The most financially relevant information is the approval of a
From a governance perspective, shareholders approved several board changes that maintain continuity while adding specialized expertise. The re-appointment of Supervisory Board members Indra Nooyi and Chua Sock Koong preserves existing oversight experience, while the addition of Bob White brings specific health technology expertise that aligns with Philips' core business focus. The shareholders also re-appointed Marnix van Ginneken to the Board of Management, with the CEO highlighting his "instrumental" role at the company.
The approval of standard corporate authorizations regarding share issuance, repurchase, and cancellation represents routine governance matters that provide management with operational flexibility. The granting of discharge to both Board of Management and Supervisory Board members indicates shareholder satisfaction with the company's governance.
The statements from Chairman Feike Sijbesma and CEO Roy Jakobs emphasize the value of experienced governance and express confidence in the board composition. The press release mentions that the 2024 financial statements were approved but refers to the Annual Report published on February 21, 2025, for specific financial details rather than including performance metrics directly.
This press release primarily addresses corporate governance procedures and dividend distribution, indicating orderly corporate functioning without revealing new strategic initiatives or specific business outlook beyond board composition adjustments.
May 8, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including:
- The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.
- The appointment of Mr Bob White as a new member of the Supervisory Board.
- The re-appointment of Mr Marnix van Ginneken as member of the Board of Management.
- The discharge of the members of the Board of Management, and of the members of the Supervisory Board.
- A full overview of the resolutions taken at the AGM 2025 can be found below.
Feike Sijbesma, Chairman of Philips’ Supervisory Board, said: “On behalf of the Supervisory Board and the Board of Management, I extend our heartfelt thanks to David Pyott for his invaluable counsel over the past decade. We are also delighted to welcome Bob White to the Supervisory Board and are very pleased with the re-appointment of Indra Nooyi and Chua Sock Koong. With our highly knowledgeable and experienced members, our Supervisory Board is well-equipped to advise and support Management as they execute Philips’ strategy.”
Mr Sijbesma added: “Together with my colleagues on the Supervisory Board, we extend our congratulations to Marnix van Ginneken on his re-appointment as a member of Philips’ Board of Management. With his strong leadership, profound understanding of the company, and his extensive international corporate governance experience, he is a tremendous asset to Philips.”
Roy Jakobs, CEO of Royal Philips, said: “I am very pleased with Bob White’s appointment to our Supervisory Board. He is a recognized global business leader with deep expertise in health technology. Philips has benefited greatly from the expertise and contributions of Indra Nooyi and Chua Sock Koong, and we are very happy with their re-appointment. Our CFO Charlotte Hanneman and I look forward to continued successful collaboration with Marnix van Ginneken who has been instrumental to Philips, as we strive to improve health and well-being of people through meaningful innovation.”
All resolutions taken at the AGM 2025:
| Agenda item | Resolution |
| 3 | Annual Report 2024
|
| 4 | Composition of the Board of Management
|
| 5 | Composition of the Supervisory Board
|
| 6 | Authorization of the Board of Management to issue shares or grant rights to acquire shares and restrict or exclude pre-emption rights |
| 7 | Authorization of the Board of Management to acquire shares in the company |
| 8 | Cancellation of shares |
Further details about the dividend can be found via this link, and additional information on the composition of the Board of Management, the Executive Committee and the Supervisory Board can be found here. Philips’ 2024 financial statements are included in its Annual Report 2024 that was published on February 21, 2025.
For more information about Philips’ AGM 2025, please click on this link.
For further information, please contact:
Michael Fuchs
Philips Global External Relations
Tel.: +31 614869261
E-mail: media@philips.com
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
- Philips AGM 2025
- Chairman Feike Sijbesma and a member of the Board of Management Marnix van Ginneken during Philips AGM 2025
FAQ
What was the dividend approved at Philips (PHG) AGM 2025?
Who are the new appointments to Philips' Supervisory Board in 2025?
Was Marnix van Ginneken reappointed to Philips' Board of Management?
What key proposals were approved at Philips' 2025 AGM?
